The present invention relates to a perfusion line for the administration of medical treatment liquids, such as chemotherapy products, to a patient, and the method for using such a perfusion line.
A perfusion line for the administration of medical treatment liquids to a patient, such as chemotherapy products, in a known manner comprises:
The method for using such a perfusion line comprises the following steps consisting in:
The use of such a perfusion line involves steps that are dangerous for hospital personnel, notably during the administration of chemotherapy products because of the handling of these products by the hospital personnel.
Specifically, during the preparation of the chemotherapy product and of the mixture of the various products forming the latter, the hospital personnel may receive splashes of the chemotherapy product or inhale vapours of the active principle of the chemotherapy product.
In addition, the hospital personnel and the patient may also receive splashes of the chemotherapy product or inhale vapours of this product during the disconnection of the catheter extender since a considerable quantity of chemotherapy product still remains inside the extender.
In addition, the presence of a considerable quantity of chemotherapy product in the extender at the end of use of the perfusion line constitutes a waste of product and involves discarding waste that is hazardous for the environment.
The technical problem at the base of the invention is therefore the production of a perfusion line for the administration of medical treatment liquids that has a simple and economic structure, whose use makes it possible to protect a user and the patient to be treated from any contact with the treatment liquids intended to be administered to the latter, while protecting the environment.
Accordingly, the present invention relates to a perfusion line for the administration of medical treatment liquids, such as chemotherapy products, to a patient, characterized in that it comprises:
It should be noted that “chemotherapy product” means any product allowing the treatment of a cancer.
Preferably, the stopping means comprise an elastically deformable split stopper.
Advantageously, the means of connection to an element forming a catheter comprise a fitting of the male luer-lock type.
According to one embodiment of the invention, the luer type connector means of each fluid inlet way comprise a fitting of the female luer-lock type.
Preferably, the tap is a three-way tap.
The present invention also relates to a method of using a perfusion line according to the invention, characterized in that it comprises the steps consisting in:
Flushing the extender with a flushing product after the step for injecting the treatment liquid makes it possible to ensure a discharge of substantially all of the medical treatment liquid contained in the extender, and therefore preventing on the one hand a waste of product and on the other hand a splashing of treatment liquid on the patient or the hospital personnel during the disconnection of the catheter extender.
In addition, since substantially all the medical treatment liquid contained in the extender is discharged from the latter, the discarded waste is much less harmful for the environment.
Consequently, the method of use according to the invention makes it possible to protect the environment and to limit the risks of contact with the treatment liquids for the hospital personnel and the patient to be treated.
Preferably, the method comprises a step of filling the administration receptacle produced before the step of injecting the medical treatment liquid and consisting in:
The presence of the deformable and movable stopping means on the inlet way of the tap that receives the preparation receptacle makes it possible to prevent any splashing or running of treatment liquid during the disconnection of the preparation receptacle.
Therefore, the method of use according to the invention protects the hospital personnel and the patient to be treated from any contact with the treatment liquid during the filling of the administration receptacle.
Advantageously, the step of filling the administration receptacle comprises the steps consisting in:
The use of a tap having two fluid inlet ways makes it possible to produce the mixture of the various products constituting the medical treatment liquid in a closed circuit and therefore to protect the hospital personnel and the patient to be treated from any contact with the medical treatment liquid.
Preferably, the step of filling the administration receptacle comprises a step consisting in disconnecting the second flushing receptacle after the injection of the predetermined quantity of flushing product into the administration receptacle.
Advantageously, the method comprises a step consisting in disconnecting the first flushing receptacle after the draining of the tap and of the extender.
According to one mode of applying the method, the step of flushing the extender consists in connecting a third flushing receptacle containing a flushing product, such as physiological serum or glucose, to the luer type connector means of one of the fluid inlet ways of the tap comprising deformable or movable stopping means, and in injecting into the extender a predetermined quantity of the flushing product contained in the third flushing receptacle.
According to another mode of applying the method, the step of flushing the extender consists in injecting flushing product into the extender directly from the first flushing receptacle used during the step of draining the tap and the extender.
Preferably, each flushing receptacle is a flushing syringe. Advantageously, the administration receptacle is an administration syringe, and the preparation receptacle is a preparation syringe.
However, according to one embodiment of the method, at least one or all of the receptacles could be bags directly connected to the luer type connector means of the fluid inlet ways of the tap or connected to the latter by means of extension lines having complementary luer type connector means.
Preferably, the medical treatment liquid is a chemotherapy product.
In any case, the invention will be fully understood with the aid of the following description with reference to the appended schematic drawing representing, as a non-limiting example, a form of execution of this perfusion line.
The perfusion line 2 comprises a three-way tap 3 comprising a first fluid inlet way 4 and a second fluid inlet way 5 and a fluid outlet way 6.
Each fluid inlet way 4, 5 is fitted with means for connection to a syringe. The means for connection to a syringe of each fluid inlet way comprise a fitting 7 of the female luer-lock type.
The first fluid inlet way 4 comprises stopping means that can be deformed between a first position in which the stopping means prevent a flow of fluid through the first fluid inlet way, and a second position in which the stopping means allow a flow of fluid through the first fluid inlet way. The stopping means are arranged in order to be deformed into the second position during the connection of a needleless syringe to the first fluid inlet way.
The stopping means preferably comprise an elastically deformable split stopper (not shown in the figures) housed in a rigid tubular fitting 8 and mounted on the first fluid inlet way. The edges delimiting the split of the elastically deformable stopper are arranged so as to separate elastically from one another during the connection of a needleless syringe to the first fluid inlet way so as to allow a flow of fluid through the split and therefore through the first fluid inlet way, and so as to elastically return towards one another during the disconnection of the needleless syringe from the first fluid inlet way so as to prevent a flow of fluid through the split and therefore through the first fluid inlet way. The elastically deformable split stopper consequently forms a self-stoppable inlet valve.
The second fluid inlet way 5 comprises a stopping plug 9 arranged to interact with the luer-lock type fitting of the latter.
The tap 3 comprises a handle 11 that can be rotated between a first position allowing a flow of fluid between the first fluid inlet way 4 and the second fluid inlet way 5, a second position allowing a flow of fluid between the first fluid inlet way 4 and the fluid outlet way 6, and a third position allowing a flow of fluid from the second fluid inlet way 5 and the fluid outlet way 6.
The perfusion line 2 also comprises an extender 12 whose proximal end 13 is mounted on the fluid outlet way 6 of the tap and whose distal end 14 is fitted with means of connection to a catheter. The means of connection to a catheter comprise a fitting 15 of the male luer-lock type. The extender 12 comprises a stopping plug 16 arranged to interact with the fitting 15 of the male luer-lock type.
The method for using the perfusion line 2 will now be described with reference to
The method of use comprises a first step of draining the tap 3 and the extender 12 consisting in:
The method of use comprises a second step of filling an administration syringe consisting in:
The method of use comprises a third step of administering the chemotherapy product consisting in:
The method of use finally comprises a fourth step of flushing the extender 12 consisting in:
According to an alternative application of the method of use, the second step of filling and the third step of administration are replaced by a step of administration of a chemotherapy product consisting in:
According to another alternative of the method of use, the step of flushing the extender consists in injecting the flushing product into the extender 12 directly from the first flushing syringe 17 used during the step of draining the tap 3 and the extender 12.
It goes without saying that the invention is not limited solely to the form of execution of this perfusion line described above as an example; on the contrary, it covers all the variant embodiments.
Number | Date | Country | Kind |
---|---|---|---|
08 02893 | May 2008 | FR | national |
This application is related to U.S. Provisional Patent Application Ser. No. 61/057,095 filed on 29 May 2008 and further claims priority under 35 U.S.C. 119(a) to French patent application Ser. No. 08/02893 filed on 28 May 2008, which both of said applications are herein incorporated by reference in their entirety.
Number | Date | Country | |
---|---|---|---|
61057095 | May 2008 | US |